Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia

Por Ossenkoppele, Gert J., Janssen, Jeroen J.W.M., van de Loosdrecht, Arjan A.
Publicado no Haematologica (2016)

Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation

Por Bouwman, Linda, Eeltink, Corien M., Visser, Otto, Janssen, Jeroen J. W. M., Maaskant, Jolanda M.
Publicado no BMC Cancer (2017)

Methylation patterns in CD34 positive chronic myeloid leukemia blast crisis cells

Por Janssen, Jeroen J.W.M., Denkers, Fedor, Valk, Peter, Cornelissen, Jan J., Schuurhuis, Gerrit-Jan, Ossenkoppele, Gert J.
Publicado em 2010

Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy

Por Wilhelm, Abraham J, de Graaf, Peer, Veldkamp, Agnes I, Janssen, Jeroen J W M, Huijgens, Peter C, Swart, Eleonora L
Publicado em 2012

Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands

Por Jansen, Jeroen P., O’Sullivan, Amy K., Lugtenburg, Elly, Span, Lambert F. R., Janssen, Jeroen J. W. M., Stam, Wiro B.
Publicado em 2010

Patient satisfaction with information on oral anticancer agent use

Por Boons, Christel C. L. M., Timmers, Lonneke, van Schoor, Natasja M., Swart, Eleonora L., Hendrikse, N. Harry, Janssen, Jeroen J. W. M., Hugtenburg, Jacqueline G.
Publicado no Cancer Med (2017)

Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemia

Por Geelen, Inge G.P., Thielen, Noortje, Janssen, Jeroen J.W.M., Hoogendoorn, Mels, Roosma, Tanja J.A., Willemsen, Sten P., Visser, Otto, Cornelissen, Jan J., Westerweel, Peter E.
Publicado no Haematologica (2017)

Impact of hospital experience on the quality of tyrosine kinase inhibitor response monitoring and consequence for chronic myeloid leukemia patient survival

Por Geelen, Inge G.P., Thielen, Noortje, Janssen, Jeroen J.W.M., Hoogendoorn, Mels, Roosma, Tanja J.A., Willemsen, Sten P., Valk, Peter J.M., Visser, Otto, Cornelissen, Jan J., Westerweel, Peter E.
Publicado no Haematologica (2017)

Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis

Por Hochhaus, Andreas, Mahon, Franҫois-Xavier, le Coutre, Philipp, Petrov, Ljubomir, Janssen, Jeroen J. W. M., Cross, Nicholas C. P., Rea, Delphine, Castagnetti, Fausto, Hellmann, Andrzej, Rosti, Gianantonio, Gattermann, Norbert, Coronel, Maria Liz Paciello, Gutierrez, Maria Asuncion Echeveste, Garcia-Gutierrez, Valentin, Vincenzi, Beatrice, Dezzani, Luca, Giles, Francis J.
Publicado no J Cancer Res Clin Oncol (2017)

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Por Cloos, Jacqueline, Harris, Jeffrey R., Janssen, Jeroen J.W.M., Kelder, Angele, Huang, F., Sijm, Gerrit, Vonk, Maike, Snel, Alexander N., Scheick, Jennifer R., Scholten, Willemijn J., Carbaat-Ham, Jannemieke, Veldhuizen, Dennis, Hanekamp, Diana, Oussoren-Brockhoff, Yvonne J.M., Kaspers, Gertjan J.L., Schuurhuis, Gerrit J., Sasser, A. Kate, Ossenkoppele, Gert
Publicado no J Vis Exp (2018)

Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia

Por Deenik, Wendy, Janssen, Jeroen J.W.M., van der Holt, Bronno, Verhoef, Gregor E.G., Smit, Willem M., Kersten, Marie José, Daenen, Simon M.G.J., Verdonck, Leo F., Ferrant, Augustin, Schattenberg, Anton V.M.B., Sonneveld, Pieter, van Marwijk Kooy, Marinus, Wittebol, Shulamit, Willemze, Roelof, Wijermans, Pierre W., Beverloo, H. Berna, Löwenberg, Bob, Valk, Peter J.M., Ossenkoppele, Gert J., Cornelissen, Jan J.
Publicado em 2010